Metraipolis › archive › dc_56990ceeec3a

Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer — Europe PMC PMID:42798783

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42798783
DOI
10.1002/mco2.71009
License (as archived)
solo-consultazione
Archived
2026-10-07T21:18:31.406Z
SHA-256 of the archived text
06832fe33d27124446cf7dc66e268957e835b9805acd7ba828a5b37b2d73febe
Stable URL of this page
https://metraipolis.com/documento/dc_56990ceeec3a

How to cite

Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer — Europe PMC PMID:42798783 — Europe PMC (en), https://europepmc.org/article/MED/42798783 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_56990ceeec3a (Metraipolis archive dc_56990ceeec3a, sha256 06832fe33d27124446cf7dc66e268957e835b9805acd7ba828a5b37b2d73febe)
BibTeX
@misc{dc56990ceeec3a,
  title = {Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer — Europe PMC PMID:42798783},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42798783},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_56990ceeec3a; sha256 06832fe33d27124446cf7dc66e268957e835b9805acd7ba828a5b37b2d73febe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42798783. Agents can read the archived copy with the MCP tool read_document.